QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
OTCMKTS:RCAR

RenovaCare - RCAR Stock Forecast, Price & News

$0.19
+0.01 (+5.60%)
(As of 02/8/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.19
▼
$0.30
50-Day Range
$0.02
▼
$0.19
52-Week Range
$0.01
▼
$0.36
Volume
57,117 shs
Average Volume
22,609 shs
Market Capitalization
$16.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RCAR stock logo

About RenovaCare (OTCMKTS:RCAR) Stock

RenovaCare, Inc. operates as a development stage company, which engages in the research, development, and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. Its flagship technology is the CellMist System, which is a treatment methodology for cell isolation for the regeneration of human skin cells and other tissues, and a solution sprayer device for delivering cells to the treatment area. The company was founded on July 14, 1983 and is headquartered in Scottsdale, AZ.

Receive RCAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RenovaCare and its competitors with MarketBeat's FREE daily newsletter.

RCAR Stock News Headlines

September 27, 2022 | reuters.com
RCAR.PK - RenovaCare Inc | Stock Price & Latest News | Reuters
August 16, 2022 | businesswire.com
Global Burns Market Report to 2032 - Insight, Epidemiology and Forecasts - ResearchAndMarkets.com - Business Wire
February 8, 2023 | Vantage Point (Ad)
3 Secrets To Consistent Trading Success
Don't get caught in the trap of standing on the sidelines of intermarket correlation. The truth is that it’s impossible for you (or any human) to visualize and calculate complicated intermarket causations. Learn with A.I. which global markets have the most influence on a target market. Save a Seat for This Free Live Training. pixel
August 13, 2022 | streetinsider.com
Form 10-Q RenovaCare, Inc. For: Jun 30 - StreetInsider.com
May 13, 2022 | globenewswire.com
Lifshitz Law PLLC Announces Investigations of CorMedix Inc. (NASDAQGM: CRMD), FirstCash Holdings, Inc. (NASDAQ: FCFS), NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), Renovacare, Inc. (OTC-BB: RCAR) - GlobeNewswire
May 4, 2022 | globenewswire.com
RenovaCare Announces Termination of StemCell Systems R&D Agreement - GlobeNewswire
May 3, 2022 | finance.yahoo.com
RenovaCare Announces Termination of StemCell Systems R&D Agreement - Yahoo Finance
May 3, 2022 | finance.yahoo.com
RenovaCare Announces Termination of StemCell Systems R&D Agreement
February 8, 2023 | Vantage Point (Ad)
3 Secrets To Consistent Trading Success
Don't get caught in the trap of standing on the sidelines of intermarket correlation. The truth is that it’s impossible for you (or any human) to visualize and calculate complicated intermarket causations. Learn with A.I. which global markets have the most influence on a target market. Save a Seat for This Free Live Training. pixel
April 22, 2022 | benzinga.com
Global Skin Burns Market Insight, Epidemiology and Market Forecast 2019-2032 Featuring Pfizer, Avita Medical, Mallinckrodt & RenovaCare - Benzinga
April 19, 2022 | businesswire.com
Insights on the Global Skin Burns Market (2019 to 2032) Includes Segmentation of 7 Major Markets - ResearchAndMarkets.com - Business Wire
April 14, 2022 | benzinga.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. is Investigating RenovaCare, Inc. - Benzinga - Benzinga
April 13, 2022 | globenewswire.com
Lifshitz Law Firm, PC Announces Investigations of ATI Physical Therapy, Inc. (NYSE: ATIP), DraftKings Inc. (NASDAQGS: DKNG), Electric Last Mile Solutions, Inc., and Renovacare, Inc. (OTC-BB: RCAR) - GlobeNewswire
March 24, 2022 | seekingalpha.com
RenovaCare trims management team amid cost cutting measures
March 24, 2022 | globenewswire.com
RenovaCare Announces Management Changes - GlobeNewswire
March 24, 2022 | finance.yahoo.com
RenovaCare Announces Management Changes
March 10, 2022 | finance.yahoo.com
Iris Energy Limited Announces Monthly Investor Update for February 2022 - Yahoo Finance
March 10, 2022 | globenewswire.com
RenovaCare Provides Clinical and Corporate Update - GlobeNewswire
March 9, 2022 | finance.yahoo.com
WISeKey’s WISeID Platform Helps Individuals and Companies Reduce Cybersecurity Risks - Yahoo Finance
March 9, 2022 | finance.yahoo.com
Worldwide Continuous Renal Replacement Therapy Industry to 2027 - Ongoing Research and Development in Continuous Renal Replacement Therapy Presents Opportunities - Yahoo Finance
March 9, 2022 | finance.yahoo.com
VelocityEHS Acquires Job Analysis & Return-to-Work Management Technology Solutions from MyAbilities - Yahoo Finance
March 9, 2022 | finance.yahoo.com
Movement Industries Corporation Appoints New CFO and Increases Revenues by Approximately 84% over Previous Quarter - Yahoo Finance
March 9, 2022 | finance.yahoo.com
The opportunity within the regulatory T-cell therapies market is projected to grow at an annualized rate of ~45%, till 2035, claims Roots Analysis - Yahoo Finance
March 9, 2022 | finance.yahoo.com
Canasil Review of Candy Vein Drill Results With Up To 8,445 g/t AgEq* x Metres True Width x Grade Suggests High Potential at the Nora Silver and Gold Project, Durango, Mexico - Yahoo Finance
March 9, 2022 | finance.yahoo.com
Monument Announces Ground-breaking Ceremony Held at Selinsing For Flotation Construction in Malaysia - Yahoo Finance
March 9, 2022 | finance.yahoo.com
RenovaCare Provides Clinical and Corporate Update - Yahoo Finance
March 9, 2022 | finance.yahoo.com
RenovaCare Provides Clinical and Corporate Update
See More Headlines
Receive RCAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RenovaCare and its competitors with MarketBeat's FREE daily newsletter.

RCAR Company Calendar

Today
2/08/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:RCAR
CUSIP
N/A
CIK
1016708
Web
www.renovacareinc.com
Phone
(888) 398-0202
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,470,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-5,071.08%
Return on Assets
-251.03%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.62
Quick Ratio
0.62

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
87,350,000
Free Float
86,601,000
Market Cap
$16.48 million
Optionable
Not Optionable
Beta
1.94

Key Executives

  • Harmel S. Rayat
    Chairman, President, CEO, CFO & Secretary
  • Roger Esteban-Vives
    Vice President-Research & Product Development
  • Robin A. Robinson
    Chief Scientific Officer
  • Jo Ellen Schweinle
    Chief Medical Officer
  • Rodney L. Sparks
    Vice President-Intellectual Property & Licensing

Key Competitors

View All Competitors













RCAR Stock - Frequently Asked Questions

How have RCAR shares performed in 2023?

RenovaCare's stock was trading at $0.0201 at the beginning of 2023. Since then, RCAR shares have increased by 838.8% and is now trading at $0.1887.
View the best growth stocks for 2023 here.

Are investors shorting RenovaCare?

RenovaCare saw a increase in short interest in the month of December. As of December 30th, there was short interest totaling 2,800 shares, an increase of 27.3% from the December 15th total of 2,200 shares. Based on an average daily trading volume, of 19,000 shares, the days-to-cover ratio is presently 0.1 days.
View RenovaCare's Short Interest.

What other stocks do shareholders of RenovaCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RenovaCare investors own include Brainstorm Cell Therapeutics (BCLI), ReNeuron Group (RENE), Fulcrum Therapeutics (FULC), SCYNEXIS (SCYX), Teva Pharmaceutical Industries (TEVA), Akebia Therapeutics (AKBA), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Iovance Biotherapeutics (IOVA).

What is RenovaCare's stock symbol?

RenovaCare trades on the OTCMKTS under the ticker symbol "RCAR."

How do I buy shares of RenovaCare?

Shares of RCAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is RenovaCare's stock price today?

One share of RCAR stock can currently be purchased for approximately $0.19.

How much money does RenovaCare make?

RenovaCare (OTCMKTS:RCAR) has a market capitalization of $16.48 million. The biotechnology company earns $-4,470,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis.

How can I contact RenovaCare?

RenovaCare's mailing address is 4 BECKER FARM ROAD SUITE 105, ROSELAND NJ, 07068. The official website for the company is www.renovacareinc.com. The biotechnology company can be reached via phone at (888) 398-0202.

This page (OTCMKTS:RCAR) was last updated on 2/8/2023 by MarketBeat.com Staff